Annovis Bio, Inc.
(NYSE Amex Equities : ANVS)

( )
ANVS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -0.08%147.000.7%$950.26m
PFEPfizer Inc. -0.61%36.170.9%$870.96m
ABBVAbbVie, Inc. -0.46%86.881.9%$700.28m
MRKMerck & Co., Inc. -1.05%81.890.7%$692.78m
BMYBristol-Myers Squibb Co. 0.30%59.891.0%$665.89m
LLYEli Lilly & Co. -1.25%146.251.1%$554.08m
AZNAstraZeneca Plc 0.66%55.111.2%$255.78m
NVSNovartis AG 0.00%87.050.2%$164.16m
GSKGlaxoSmithKline Plc -1.15%37.430.2%$110.65m
PRNBPrincipia Biopharma, Inc. 0.00%100.050.0%$81.32m
NVONovo Nordisk A/S 1.52%70.220.1%$59.56m
RGENRepligen Corp. 2.25%150.597.1%$50.55m
RPRXRoyalty Pharma Plc 1.94%42.010.2%$49.45m
SNYSanofi -0.98%50.500.2%$45.68m
OPKOPKO Health, Inc. 7.86%3.4311.2%$38.09m

Company Profile

Annovis Bio, Inc. develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders. It offers posiphen compound for mild cognitive impairment and early stage Alzheimer's disease and bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.